Document Detail


Germline BRCA1 185delAG mutations in Jewish women with breast cancer.
MedLine Citation:
PMID:  8642955     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: We aimed to find out the proportion of breast cancers in Ashkenazi Jewish women attributable to the frameshift mutation at position 185 involving the deletion of adenine and guanine (185delAG) in the breast cancer gene BRCA1. METHODS: We studied 107 Ashkenazi Jewish women with breast cancer seen at medical oncology and genetic counseling clinics in New York over a three and a half year period beginning in 1992. 80 of the women were diagnosed before age 42 years; the other 27 were diagnosed between 42 and 50 years and had a positive family history. Genomic DNA testing by PCR amplification was done to identify any 185delAG mutations of the BRCA1 gene. FINDINGS: Of the 80 women diagnosed before the age of 42 years, 16 (20%, 95% CI 11.2-28.8) were heterozygous for the mutation. All 16 women had at least one first-degree or second-degree relative with breast or ovarian cancer. Of 27 probands diagnosed with breast cancer between the ages of 42 and 50 years who had at least one first-degree relative affected with breast or ovarian cancer, 8 (30%, 95% CI 12-47) had 185delAG mutations. INTERPRETATION: These data suggest that screening for the 185delAG mutation may be useful in genetic counselling of these women where options for detection and prevention of possible cancers can be discussed.
Authors:
K Offit; T Gilewski; P McGuire; A Schluger; H Hampel; K Brown; J Swensen; S Neuhausen; M Skolnick; L Norton; D Goldgar
Related Documents :
14684685 - Somatic instability of the dna sequences encoding the polymorphic polyglutamine tract o...
12619115 - Tp53 and breast cancer.
10854945 - Immunohistochemical analyses of sporadic and familial (185delag carriers) ovarian cance...
11034065 - Brca1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
3048345 - Optical spectroscopy. pre-mammography marker.
14684685 - Somatic instability of the dna sequences encoding the polymorphic polyglutamine tract o...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Lancet     Volume:  347     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  1996 Jun 
Date Detail:
Created Date:  1996-07-18     Completed Date:  1996-07-18     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1643-5     Citation Subset:  AIM; IM    
Affiliation:
Clinical Genetics Service, Department of Human Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Base Sequence
Breast Neoplasms / diagnosis,  ethnology,  genetics*
DNA, Neoplasm / genetics
Female
Germ-Line Mutation*
Humans
Jews*
Middle Aged
Molecular Sequence Data
Polymerase Chain Reaction
Grant Support
ID/Acronym/Agency:
P20 CA 58232/CA/NCI NIH HHS; R01 CA 55914/CA/NCI NIH HHS; R01 CA 65673/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/DNA, Neoplasm
Comments/Corrections
Comment In:
Lancet. 1996 Jun 15;347(9016):1638-9   [PMID:  8642950 ]
Lancet. 1996 Aug 17;348(9025):477   [PMID:  8709806 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A noninvasive evaluation of baroreceptor sensitivity with the Valsalva maneuver and phenylephrine me...
Next Document:  Jewish religion and risk of breast cancer.